Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/11/1998 | EP0877094A2 Detection and quantification of one or more nucleotide sequence target analytes in a sample using spatially localized target analyte replication |
11/11/1998 | EP0877090A1 Process for producing l-amino acids |
11/11/1998 | EP0877088A2 Regulation of the translationinitiation in Eukaryotic cells |
11/11/1998 | EP0877087A1 Cloning vectors for Amycolatopsis sp. and a process for the preparation thereof |
11/11/1998 | EP0877086A2 Recombinant YF virus vaccines recovered from the infectious cDNA |
11/11/1998 | EP0877085A1 OspA protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
11/11/1998 | EP0877084A1 Thermostable diaphorase gene |
11/11/1998 | EP0877083A1 A novel human G-protein coupled receptor (HCEPT09) |
11/11/1998 | EP0877082A1 Gene targeting and sibling-selection to generate mutant individuals |
11/11/1998 | EP0877030A2 EPO primary response gene 1,(EPRG1) |
11/11/1998 | EP0876615A1 Peptides which enhance transport across tissues and methods of identifying and using the same |
11/11/1998 | EP0876611A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
11/11/1998 | EP0876534A1 Production of sanitary paper |
11/11/1998 | EP0876512A1 Methods for identifying inhibitors of rna viruses |
11/11/1998 | EP0876511A1 Method for analyzing repeat nucleic acid sequences |
11/11/1998 | EP0876510A1 Homogeneous amplification and detection of nucleic acids |
11/11/1998 | EP0876509A1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
11/11/1998 | EP0876507A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2C$g(a) - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
11/11/1998 | EP0876503A2 Process for assessing the activity of drugs |
11/11/1998 | EP0876502A1 Size-based marker identification technology |
11/11/1998 | EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv |
11/11/1998 | EP0876497A1 Production of recombinant baculoviruses |
11/11/1998 | EP0876496A1 An expression system for anaerobic gene expression in higher plants |
11/11/1998 | EP0876495A1 Genetically engineered yeast strains |
11/11/1998 | EP0876494A1 Production and secretion of proteins of bacterial origin in filamentous fungi |
11/11/1998 | EP0876493A1 Production of bacillus thuringiensis integrants |
11/11/1998 | EP0876492A1 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
11/11/1998 | EP0876491A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK |
11/11/1998 | EP0876490A1 Para-nitrobenzyl esterases with enhanced activity in aqueous and nonaqueous media |
11/11/1998 | EP0876489A2 Nucleic acids encoding polypeptides having absidia lipase activity |
11/11/1998 | EP0876488A1 Dna sequences coding for a protein conferring male sterility |
11/11/1998 | EP0876487A1 Mammalian cx 3?c chemokine genes |
11/11/1998 | EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
11/11/1998 | EP0876485A2 NOVEL CREBa ISOFORM |
11/11/1998 | EP0876484A1 Recombinant expression of proteins from secretory cell lines |
11/11/1998 | EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
11/11/1998 | EP0876482A1 Il-13 receptor polypeptide |
11/11/1998 | EP0876481A1 Fruit ripening-related genes |
11/11/1998 | EP0876480A1 Animals with targeted gene deletion |
11/11/1998 | EP0876476A1 Heterophil-adapted poultry vaccine |
11/11/1998 | EP0876402A1 Growth hormone secretagogue receptor family |
11/11/1998 | EP0876397A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
11/11/1998 | EP0876385A1 Topiramate immunoassay, as well as analogs and antibodies |
11/11/1998 | EP0876160A2 Ligand directed enzyme prodrug therapy |
11/11/1998 | EP0876156A1 Compositions and methods for administering borrelia burgdorferi antigens |
11/11/1998 | EP0876152A1 Novel administration of thrombopoietin |
11/11/1998 | EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application |
11/11/1998 | EP0876150A1 Non-toxic mutants of pathogenic gram-negative bacteria |
11/11/1998 | EP0876095A1 Electroporation-mediated molecular transfer in intact plants |
11/11/1998 | EP0876094A1 Method for the production of hybrid plants |
11/11/1998 | EP0859862A4 Novel diagnostic marker for splicing variants of genes associated with neurological function |
11/11/1998 | EP0701604B1 Immortalization of denditric cells with v-myc oncogene |
11/11/1998 | EP0598011B1 Ecdysteroid dependent regulation of genes in mammalian cells |
11/11/1998 | CN1198778A Aspergillus arabinofuranosidase |
11/11/1998 | CN1198777A Novel polypeptides and polynucleotides relating to the alpha- and beta- subunits of glutamate dehydrogenases and methods of use |
11/11/1998 | CN1198776A Novel DNAS and process for producing proteins by using the same |
11/11/1998 | CN1198775A Recombinant c-proteinase and processes, methods and uses thereof |
11/11/1998 | CN1198676A Glucocorticold ehancement of gene expression |
11/11/1998 | CN1198655A Transformation of cotton plants |
11/11/1998 | CN1198439A Method for extracting hologenome of giant panda |
11/10/1998 | US5834598 Having variations in amino acids ten, fourteen, eighteen and twenty-one |
11/10/1998 | US5834597 Treating disorders requiring immune suppression with fewer side effects |
11/10/1998 | US5834596 Process for purifying ApoA or ApoE |
11/10/1998 | US5834593 Genetic engineering of prion protein |
11/10/1998 | US5834592 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
11/10/1998 | US5834589 Chimeric viral receptor polypeptides |
11/10/1998 | US5834587 G-protein coupled receptor, HLTEX 11 |
11/10/1998 | US5834441 Introducing a genetic sequence into a host cell |
11/10/1998 | US5834440 Administering to human muscle cell an effective amount of dna to favor transcription of the dna to produce ribozyme |
11/10/1998 | US5834439 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
11/10/1998 | US5834425 Composite of lectin and epidermal growth factor domains, treatment of pathological leukocyte mediated inflammation |
11/10/1998 | US5834310 Mammalian muscle NAD: arginine ADP-ribosyltransferase |
11/10/1998 | US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors |
11/10/1998 | US5834307 Recombinant polynucleotide which codes for a polypeptide from a cytomegalovirus glycoprotein; for vaccines, diagnosis |
11/10/1998 | US5834306 Tissue specific hypoxia regulated therapeutic constructs |
11/10/1998 | US5834305 Purified recombinant herpes virus of turkeys (hvt) having foreign dna inserted into the region of the hvt corresponding to bamiii 16 fragment; hvt or pseudorabies promoters |
11/10/1998 | US5834303 Transformation; bacteriolysis; degradation |
11/10/1998 | US5834302 Method for producing RNA viruses from CDNA |
11/10/1998 | US5834297 Using recombinant escherichia coli containing a gene encoding a phenol hydroxylase from bacillus stearothermophilus; e.coli tryptophanase converts tryptophan to indole, which is then converted to dyes; heat stable enzyme |
11/10/1998 | US5834296 Bacillus strain and harmful organism controlling agents |
11/10/1998 | US5834292 Method for producing somaclonal variant cotton plants |
11/10/1998 | US5834291 Inviable t-even phage genome having a predetermined non-t-even base sequence cloned to and under the control of a t-even expression control sequence; host bacterium replicon homologous to phage dna to allow recombination to occur |
11/10/1998 | US5834290 Skin disorders such as acne, xeroderma, hyperkeratotic conditions, callosities and keratosis pilaris; ichthyoses, psoriasis and eczemas; autoimmune pemphigus, acatholytic diseases, familiar pemphigus and darier's disease |
11/10/1998 | US5834287 Culture product enzgyme obtained from genetic expressed microorganism; the enzyme can release trehalose from non-reducing oligo- or poly-saccharides having a trehalose structure as an end unit |
11/10/1998 | US5834286 Phytase and phosphatase enzymes from aspergillus niger; degrade phytic acid |
11/10/1998 | US5834285 Recombinant thermostable DNA polymerase from archaebacteria |
11/10/1998 | US5834284 N-acetylglucosaminyl transferase gene coding therefor and process for production thereof |
11/10/1998 | US5834283 Isolated, purified active enzyme encoded by a recombinant dna; screening for anticholesterol agents; medical diagnosis |
11/10/1998 | US5834279 Detecting inhibitors of ribonucleotide reductase or topoisomerase; for suppression of dna synthesis by mycobacterium |
11/10/1998 | US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus |
11/10/1998 | US5834269 Method of introducing exogenous genes into cultured cells or fertilized eggs |
11/10/1998 | US5834268 Producing plants with increased resistance to pests, inserting gene for production of stilbenes |
11/10/1998 | US5834267 Pure hiv antigen |
11/10/1998 | US5834266 Regulated apoptosis |
11/10/1998 | US5834265 Multifunctional RNA having self-processing activity, the preparation thereof and the use thereof |
11/10/1998 | US5834263 Method for producing 2-keto-L-gulonic acid |
11/10/1998 | US5834259 Enzymatic decarboxylation of racemic mixture |
11/10/1998 | US5834258 Stereoselective conversion of racemic mixtures of 5-substituted hydantoins with enzyme |
11/10/1998 | US5834256 Novel retroviral packaging system, transfection in human cells |
11/10/1998 | US5834255 Quantification of nucleic acid |